Skip to main content
Premium Trial:

Request an Annual Quote

Annette Taylor, Wayne Grody, Martine Piccart, Christos Sotiriou, Anne-Lise Børresen-Dale, Alan Hollingsworth, Debra Young, Bernd Brust, Susan Lambert

Kimball Genetics last week announced the selection of CEO Annette Taylor to the Department of Veteran Affairs Genomic Medicine Program Advisory Committee.
The committee is charged with establishing policies for using “genetic information to optimize medical care” and developing tests for treating common disease among veterans. Wayne Grody, professor of pathology and laboratory medicine at the University of California, Los Angeles, will chair the committee of nine advisors.

DiaGenic’s scientific advisory board will include four new breast cancer experts ­– Université Libre de Bruxelles professor of oncology Martine Piccart and assistant professor of the medical oncologyunit Christos Sotiriou, Norwegian Radium Hospital Department of Genetics head Anne-Lise Børresen-Dale, and Mercy Women’s Center medial director Alan Hollingsworth – the firm announced this week.
The board will advise the company regarding the first prototype of its gene expression signature test for breast cancer. The non-invasive test, which DiaGenic is in the process of finalizing, utilizes peripheral blood as sample material. DiaGenic will compare the performance of its prototype with selected gene probes for the development of a breast cancer gene expression signatures on the ABI TaqMan and GE Codelink low-density array platforms.

Debra Young, formerly ViOptix chief financial officer, is Ciphergen’s new vice president and CFO, the company said this week. In her new role, Young will be responsible for financial management activities for Ciphergen.
Young managed all aspects of finance, human resources, information technologies, legal and facilities at ViOptix.  


Invitrogen promoted current general manager and vice president of European operations Bernd Brust to the newly created position of senior vice president of sales for Europe and the Americas, the company announced this week. Prior to joining Invitrogen in 2004, Brust was general manager sales and marketing for GE Medical Systems Information Technologies. Susan Lambert, current vice president of European sales, will be assuming Brust’s previous role as general manager.

Filed under

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.